DAVENPORT & Co LLC Buys 75,853 Shares of Healthpeak Properties, Inc. $DOC

DAVENPORT & Co LLC lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 13.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 625,394 shares of the real estate investment trust’s stock after acquiring an additional 75,853 shares during the quarter. DAVENPORT & Co LLC’s holdings in Healthpeak Properties were worth $10,951,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Applied Finance Capital Management LLC boosted its position in Healthpeak Properties by 3.4% during the first quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust’s stock worth $357,000 after purchasing an additional 577 shares during the period. AssuredPartners Investment Advisors LLC lifted its stake in shares of Healthpeak Properties by 3.1% in the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust’s stock worth $447,000 after buying an additional 666 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in shares of Healthpeak Properties by 4.1% during the 1st quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 18,146 shares of the real estate investment trust’s stock worth $367,000 after buying an additional 722 shares during the period. CX Institutional grew its stake in Healthpeak Properties by 11.9% in the 2nd quarter. CX Institutional now owns 6,820 shares of the real estate investment trust’s stock valued at $119,000 after buying an additional 726 shares during the last quarter. Finally, TCTC Holdings LLC raised its holdings in Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 751 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analysts Set New Price Targets

DOC has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Wells Fargo & Company decreased their target price on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an “outperform” rating in a report on Wednesday, July 30th. Morgan Stanley cut their price target on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, August 22nd. Finally, Scotiabank cut Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and reduced their price objective for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.33.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker acquired 1,490 shares of Healthpeak Properties stock in a transaction on Monday, August 4th. The shares were bought at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the purchase, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have purchased a total of 8,783 shares of company stock worth $150,129 over the last three months. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Trading Down 0.6%

Shares of DOC stock opened at $19.25 on Tuesday. The firm has a fifty day moving average of $17.90 and a 200-day moving average of $17.99. The stock has a market cap of $13.38 billion, a price-to-earnings ratio of 80.21, a P/E/G ratio of 2.50 and a beta of 1.09. Healthpeak Properties, Inc. has a 52-week low of $16.63 and a 52-week high of $23.26. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business had revenue of $694.35 million for the quarter, compared to analysts’ expectations of $697.14 million. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The firm’s revenue for the quarter was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently announced a oct 25 dividend, which will be paid on Thursday, October 30th. Stockholders of record on Friday, October 17th will be issued a $0.1017 dividend. Healthpeak Properties’s payout ratio is 508.33%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.